Table 1.
Clinical and pathological characterization of non-IBC versus IBC patients.
| Characteristic | Non-IBC | IBC | P value |
|---|---|---|---|
| (N = 33) | (N = 28) | ||
| Age [year] | |||
| Range | 34–72 | 29–56 | 0.253a |
| Mean ± SD | 53 ± 10.1 | 50.2 ± 10.4 | |
| Tumour size [cm] | |||
| Mean ± SD | 4.3 ± 2.5 | 5.32 ± 2.3 | 0.007*,b |
| ≤4 | 22 (66.7%) | 9 (32.1%) | |
| >4 | 11 (33.3%) | 19 (67.9%) | |
| Tumour grade | |||
| G1 | 4 (12.1%) | 0 (0%) | 0.046*,b |
| G2 | 26 (78.8%) | 19 (67.8%) | |
| G3 | 3 (9.1%) | 8 (28.6%) | |
| G4 | 0 (0%) | 1 (3.6%) | |
| Axillary lymph node metastasis | |||
| ≤4 | 24 (72.7%) | 6 (21.4%) | 0.002*,b |
| >4 | 9 (27.3%) | 22 (78.6%) | |
| Lymphovascular invasion | |||
| Negative | 28 (84.8%) | 8 (28.6%) | 0.001**,b |
| Positive | 5 (15.2%) | 20 (71.4%) | |
| ER | |||
| Negative | 17 (51.5%) | 16 (57.1%) | 0.428b |
| Positive | 16 (48.5%) | 12 (42.9%) | |
| PR | |||
| Negative | 19 (57.6%) | 16 (57.1%) | 0.589b |
| Positive | 14 (42.4%) | 12 (42.9%) | |
| Her-2 | |||
| Negative | 27 (81.8%) | 23 (82.1%) | 0.621b |
| Positive | 6 (18.2%) | 5 (17.9%) | |
Data are reported as the mean ± SD, numbers and percentage.
Statistical significance.
a
Student’s t test.
b
Chi square test.
*
P ≤ 0.05.
**
P ≤ 0.001.